X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6765) 6765
Publication (634) 634
Newspaper Article (384) 384
Newsletter (291) 291
Book Review (91) 91
Book Chapter (88) 88
Magazine Article (37) 37
Book / eBook (14) 14
Trade Publication Article (14) 14
Report (12) 12
Conference Proceeding (11) 11
Government Document (10) 10
Reference (7) 7
Web Resource (5) 5
Transcript (4) 4
Dissertation (3) 3
Journal / eJournal (2) 2
Data Set (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tuberculosis (5948) 5948
humans (4290) 4290
index medicus (3652) 3652
infectious diseases (1882) 1882
female (1879) 1879
male (1820) 1820
drug resistance (1787) 1787
adult (1624) 1624
mortality (1416) 1416
antitubercular agents - therapeutic use (1392) 1392
middle aged (1223) 1223
mycobacterium-tuberculosis (1169) 1169
pulmonary tuberculosis (1123) 1123
research (1046) 1046
diagnosis (1013) 1013
public health (1007) 1007
mycobacterium tuberculosis (998) 998
epidemiology (983) 983
risk factors (972) 972
health aspects (950) 950
hiv (946) 946
medicine (940) 940
care and treatment (927) 927
mycobacterium tuberculosis - drug effects (903) 903
microbiology (885) 885
human immunodeficiency virus--hiv (876) 876
research article (872) 872
tuberculosis, multidrug-resistant - drug therapy (871) 871
drug resistance in microorganisms (816) 816
patients (814) 814
adolescent (797) 797
drug therapy (793) 793
analysis (792) 792
infections (791) 791
tuberculosis - epidemiology (780) 780
tuberculosis - drug therapy (708) 708
immunology (685) 685
aged (684) 684
treatment outcome (684) 684
medicine, general & internal (663) 663
respiratory system (659) 659
multidrug-resistant tuberculosis (647) 647
tuberculosis, multidrug-resistant - epidemiology (637) 637
antitubercular agents (628) 628
prevalence (626) 626
young adult (602) 602
antitubercular agents - pharmacology (576) 576
multidisciplinary sciences (573) 573
tuberculosis, pulmonary - drug therapy (543) 543
child (540) 540
mycobacterium tuberculosis - isolation & purification (539) 539
medical research (531) 531
infection (530) 530
retrospective studies (521) 521
studies (512) 512
mycobacterium tuberculosis - genetics (510) 510
public, environmental & occupational health (492) 492
tuberculosis - prevention & control (482) 482
animals (481) 481
science (472) 472
disease (444) 444
rifampin (438) 438
tuberculosis - diagnosis (434) 434
hospitals (426) 426
tuberculosis, pulmonary - epidemiology (413) 413
prevention (406) 406
drugs (404) 404
incidence (402) 402
hiv infections - complications (393) 393
microbial sensitivity tests (391) 391
antibiotics (386) 386
acquired immune deficiency syndrome--aids (379) 379
pharmacology & pharmacy (379) 379
bacteria (373) 373
tuberculosis, pulmonary - diagnosis (371) 371
laboratories (370) 370
global health (369) 369
infectious disease (368) 368
child, preschool (365) 365
tuberculosis - microbiology (361) 361
tuberculosis, multidrug-resistant - diagnosis (357) 357
tuberculosis, multidrug-resistant - microbiology (353) 353
aids (351) 351
medicine, experimental (347) 347
usage (332) 332
risk-factors (323) 323
human immunodeficiency virus (321) 321
patient outcomes (318) 318
children (312) 312
hiv infections - epidemiology (311) 311
infectious and parasitic diseases (311) 311
infant (309) 309
hiv infection (307) 307
internal medicine (302) 302
management (300) 300
abridged index medicus (298) 298
disease transmission (295) 295
epidemics (295) 295
bacterial diseases (291) 291
drug-resistance (291) 291
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7339) 7339
French (54) 54
Spanish (40) 40
Portuguese (32) 32
German (27) 27
Russian (20) 20
Japanese (19) 19
Korean (12) 12
Chinese (6) 6
Romanian (6) 6
Ukrainian (6) 6
Dutch (4) 4
Arabic (3) 3
Danish (3) 3
Polish (3) 3
Turkish (3) 3
Lithuanian (2) 2
Swedish (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Infectious Diseases, ISSN 0022-1899, 8/2007, Volume 196, Issue 1, pp. s86 - s107
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 23, pp. 2151 - 2160
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2014, Volume 371, Issue 8, pp. 723 - 732
Journal Article
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10195, pp. 299 - 300
[...]this situation occurred only for a few analyses—primarily for the injectables and fluoroquinolones (see table 3 in our Article,1 although this was not the... 
Antitubercular Agents | Humans | Tuberculosis, Multidrug-Resistant | Fluoroquinolones | Drugs | Linezolid | Multidrug resistant organisms | Salvage | Sensitivity analysis | Tuberculosis | Medical treatment | Mortality | Drug resistance | Subgroups | Clinical outcomes
Journal Article
by Ahmad, Nafees and Ahuja, Shama D and Akkerman, Onno W and Alffenaar, Jan-Willem C and Anderson, Laura F and Baghaei, Parvaneh and Bang, Didi and Barry, Pennan M and Bastos, Mayara L and Behera, Digamber and Benedetti, Andrea and Bisson, Gregory P and Boeree, Martin J and Bonnet, Maryline and Brode, Sarah K and Brust, James C M and Cai, Ying and Caumes, Eric and Cegielski, J Peter and Centis, Rosella and Chan, Pei-Chun and Chan, Edward D and Chang, Kwok-Chiu and Charles, Macarthur and Cirule, Andra and Dalcolmo, Margareth Pretti and D'Ambrosio, Lia and de Vries, Gerard and Dheda, Keertan and Esmail, Aliasgar and Flood, Jennifer and Fox, Gregory J and Fréchet-Jachym, Mathilde and Fregona, Geisa and Gayoso, Regina and Gegia, Medea and Gler, Maria Tarcela and Gu, Sue and Guglielmetti, Lorenzo and Holtz, Timothy H and Hughes, Jennifer and Isaakidis, Petros and Jarlsberg, Leah and Kempker, Russell R and Keshavjee, Salmaan and Khan, Faiz Ahmad and Kipiani, Maia and Koenig, Serena P and Koh, Won-Jung and Kritski, Afranio and Kuksa, Liga and Kvasnovsky, Charlotte L and Kwak, Nakwon and Lan, Zhiyi and Lange, Christoph and Laniado-Laborín, Rafael and Lee, Myungsun and Leimane, Vaira and Leung, Chi-Chiu and Leung, Eric Chung-Ching and Li, Pei Zhi and Lowenthal, Phil and Maciel, Ethel L and Marks, Suzanne M and Mase, Sundari and Mbuagbaw, Lawrence and Migliori, Giovanni B and Milanov, Vladimir and Miller, Ann C and Mitnick, Carole D and Modongo, Chawangwa and Mohr, Erika and Monedero, Ignacio and Nahid, Payam and Ndjeka, Norbert and O'Donnell, Max R and Padayatchi, Nesri and Palmero, Domingo and Pape, Jean William and Podewils, Laura J and Reynolds, Ian and Riekstina, Vija and Robert, Jérôme and Rodriguez, Maria and Seaworth, Barbara and Seung, Kwonjune J and Schnippel, Kathryn and Shim, Tae Sun and Singla, Rupak and Smith, Sarah E and Sotgiu, Giovanni and Sukhbaatar, Ganzaya and Tabarsi, Payam and Tiberi, Simon and Trajman, Anete and Trieu, Lisa and Udwadia, Zarir F and van der Werf, Tjip S and Veziris, Nicolas and Viiklepp, Piret and ... and The Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017 and Collaborative Grp Meta-Analysis In and Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 821 - 834
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of... 
DRUG | SURGERY | SOUTH-AFRICA | BEDAQUILINE | MEDICINE, GENERAL & INTERNAL | HIGH-RATES | MANAGEMENT | SAFETY | XDR-TB | REGIMENS | PROGRAM | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Medical services | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e58664
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 09/2013, Volume 18, Issue 9, pp. 1134 - 1140
Objectives In high‐tuberculosis (TB)‐endemic countries, comorbidity of pulmonary TB in hospitalised patients with non‐communicable diseases is well documented.... 
MDR‐TB | Xpert® MTB/RIF assay | tuberculosis | specificity | sub‐Saharan Africa | gynaecology | obstetric | sensitivity | multidrug‐resistant TB | maternal | women | Gynaecology | Women | Maternal | Sensitivity | Specificity | Multidrug-resistant TB | Tuberculosis | Xpert | MTB/RIF assay | MDR-TB | Obstetric | Sub-Saharan Africa | SOUTH-AFRICA | multidrug-resistant TB | RISK | PREVALENCE | HUMAN-IMMUNODEFICIENCY-VIRUS | MATERNAL MORTALITY | TROPICAL MEDICINE | Xpert((R)) MTB | sub-Saharan Africa | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HIV | RIF assay | INFANTS | EXPOSURE | Sputum - microbiology | Prospective Studies | Bacteriological Techniques - methods | HIV Infections - epidemiology | Humans | Tuberculosis, Multidrug-Resistant - diagnosis | Young Adult | HIV Infections - diagnosis | Sensitivity and Specificity | Adult | Female | Zambia - epidemiology | Microbial Sensitivity Tests - instrumentation | Pregnancy Complications, Infectious - diagnosis | Obstetrics and Gynecology Department, Hospital - statistics & numerical data | Comorbidity | Pregnancy Complications, Infectious - epidemiology | Bacteriological Techniques - instrumentation | Inpatients - statistics & numerical data | Tuberculosis, Multidrug-Resistant - epidemiology | Genital Diseases, Female - epidemiology | Mycobacterium tuberculosis - isolation & purification | Pregnancy | Tuberculosis, Pulmonary - diagnosis | Genital Diseases, Female - diagnosis | Tuberculosis, Pulmonary - epidemiology | Microbial Sensitivity Tests - methods | Drug resistance in microorganisms | Ethambutol | Usage | Rifampin | Hospitals | Diagnostic tests | Gynecology | Medical screening | Obstetrics | Xpert® MTB | Hälsovetenskap | Klinisk medicin | Medicin och hälsovetenskap | Klinisk laboratoriemedicin | Infektionsmedicin | Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi
Journal Article